Nicotine Addiction R&D Pipeline Analysis Report, H2-2018

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
34
Nicotine Addiction R&D Pipeline Analysis Report, H2-2018

Dublin, Jan. 18, 2019 (GLOBE NEWSWIRE) -- The "Nicotine Addiction R&D Pipeline Analysis Report, H2-2018" report has been added to ResearchAndMarkets.com's offering. The Nicotine Addiction pipeline guide presents complete overview of drugs currently being developed for Nicotine Addiction. The pipeline review provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drug development phase, current stage, mechanism of action, route of administration, orphan drug/ fast track/ other designations, drug class are provided for each of the Nicotine Addiction pipeline candidate. Research and Development progress along with latest news related to each of the Nicotine Addiction pipeline candidates is included. Major companies participating in therapeutic development of Nicotine Addiction are included in this pipeline report. Company wise pre clinical and clinical products along with details of drug originator, co developers/ licensors are provided. Amid strong interest for cure of Nicotine Addiction from companies and institutes, the current research work serves as a reliable and comprehensive source of information of global Nicotine Addiction clinical and pre clinical products. The report assists in identifying potential upcoming companies and drugs in Nicotine Addiction pipeline market along with progress of each drug. It also enables users to formulate effective strategies to stay ahead of competition. Scope of Nicotine Addiction pipeline report includes

  • Panorama of Nicotine Addiction pipeline markets including statistics on therapeutic drugs and companies involved
  • Nicotine Addiction Pipeline candidates across various development phases including both pre clinical, discovery and clinical stages are covered
  • Nicotine Addiction pipeline candidates across various Mechanism of Actions' are also presented in the study
  • Overview of companies participating in Nicotine Addiction pipeline with short introduction to their businesses and pipeline projects
  • For each pipeline candidate, drug overview, details of mechanism of Action (MOA), originator, co developer and licensee are provided.
  • Research and Development progress and trial details, results wherever available, are also included in the pipeline study
  • The pipeline study provides information on all ongoing and active projects and also presents the recent news associated with Nicotine Addiction pipeline therapeutics

Key Topics Covered: I. Key Findings 1. Companies Investing in Nicotine Addiction Pipeline include Number of Companies with Nicotine Addiction projects in pre clinical Development Number of Companies with Nicotine Addiction projects in Clinical Development Nicotine Addiction Pipeline Companies based in Americas Nicotine Addiction Pipeline Companies based in Europe Nicotine Addiction Pipeline Companies based in Asia Pacific Nicotine Addiction Pipeline Companies based in Rest of the World 2. Pipeline Candidates include Nicotine Addiction Pipeline Agents in pre clinical/ Discovery stage of Development Nicotine Addiction Pipeline Agents in Clinical Development stage Nicotine Addiction Pipeline Therapeutic Compounds received special status Mechanism of Action of most pipeline Drugs Small molecules among the Nicotine Addiction Pipeline agents II. Insights into Nicotine Addiction Pipeline - 1. Disease Overview Introduction to Nicotine Addiction Symptoms and Causes of Nicotine Addiction Treatment or Prevention Options for Nicotine Addiction Other Details 2. Phase wise Pipeline Compounds Nicotine Addiction Pipeline Pre Clinical/ Discovery stage Drugs Nicotine Addiction Pipeline Phase 1 stage Drugs Nicotine Addiction Pipeline Phase 2 stage Drugs Nicotine Addiction Pipeline Phase 3 stage Drugs Nicotine Addiction Pipeline Pre Registration stage Drugs 3. Company wise Nicotine Addiction Pipeline Compounds 4. Nicotine Addiction Pipeline by Mechanism of Action III. Nicotine Addiction Pipeline Compound Details Drug Details 1. Snapshot Name of the Therapeutic Agent Originator Developing Company Co Developer/ License Partner Orphan Drug / Fast Track/ Designation Development Phase 2. Drug Overview 3. Mechanism of Action 4. Current Status 5. Clinical Trial Details IV. Nicotine Addiction Pipeline Company Briefs V. Latest News and Developments in Global Nicotine Addiction Pipeline Market VI. Appendix For more information about this report visit https://www.researchandmarkets.com/research/6...otine?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Addiction Disorders Drugs

Scroll down for more posts ▼

Top 10 Most Recent News Articles

HI-CHEW® Holiday Mix Debuts Three Seasonal Flavors

Updated Category News Views 82

HI-CHEW® Puts Holiday Cheer on the Shelves In the candy aisle, it’s never just about sugar—it’s about the flavor journey. This year, HI-CHEW® is pulling off a sweet, festive coup with its first-ever Holiday Mix, making sure that your taste buds aren't left out in the cold. But hey, I’m a seasoned investor talking about candy here, not stocks. Unwrapping the New...

Continue Reading
Maternal Role in Type 1 Diabetes: A Non-Genetic Angle

Updated Category News Views 6

Unveiling the Maternal Puzzle in Type 1 Diabetes So here's a stumper: how come kids of moms with type 1 diabetes dodge the disease more than kids of dads with it? Simple genes don't account for it, says a study from University of Colorado Anschutz. With nearly 7,000 kids in this research, you'd think they'd find a genetic smoking gun. Nope. It's pointing to something else...

Continue Reading
Sokolove Law Wins $28.8M Verdict for Misdiagnosis Case

Updated Category News Views 41

Jury Awards $28.8 Million in Misdiagnosis Case Well, here's a tale that's bound to ruffle some feathers in the medical community—$28.8 million tossed on the table because an emergency room missed a life-threatening aortic aneurysm. For the uninitiated, this isn't just chump change; it's the cost of dropping the ball when the stakes are as high as a human life. A jury in...

Continue Reading
O-I Glass Faces Legal Storm Over Misleading Investor Claims

Updated Category News Views 101

Turbulence Hits O-I Glass Stock Another day, another company in hot water—and today, it's O-I Glass, Inc. (NYSE: OI) we're talking about. The company's shares plummeted by 15.01% in one fell swoop on July 29, 2026, right after it dropped its financial bombshell. Let’s break this drama down, shall we? The Legal Brass Tacks Investors who took the bait on O-I Glass...

Continue Reading
New CEO Aims to Revolutionize Pregnancy Health Sector

Updated Category News Views 125

Revolution Brewing in Pregnancy Health Look, I’ve seen all sorts of execs take on new gigs, but when I hear about an industry veteran like David Stern stepping in as CEO at Mirvie, I sit up and take notice. It’s not just another leadership shuffle; it’s a potential game-changer for a slice of healthcare that’s long been due for an overhaul. Stern’s got a track...

Continue Reading
Yiddish Prescription Labels Extend Language Access in NY

Updated Category News Views 48

Here's something that might fly under the radar unless you're really in tune with how language impacts healthcare—RxTran's move to include Yiddish on prescription labels might not be rocking financial markets, but it's got a punchy little implication for those of us watching where healthcare intersects with real-world needs. A Push Toward Accessibility Healthcare...

Continue Reading
AppLovin Faces Fraud Lawsuit, Investors Alerted

Updated Category News Views 57

AppLovin's Lawsuit: A Wake-Up Call for Investors The market never forgets, even if some investors might wish reality wasn’t so harsh. On the chopping block this time is AppLovin Corporation (NASDAQ: APP). Seems like their fairy tale with AI turned into a courtroom drama, one that’s throwing a real curveball on those rosy earnings expectations. What's the Case All...

Continue Reading
FFR Schedules Q3 2026 Earnings Call for November 12

Updated Category News Views 104

FFR: On The Edge of Q3 2026 Results Ah, another quarter chock-full of intrigue over at FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR). With their third quarter financial results dropping on November 12, anxious investors are waiting to see some solid numbers amid the clouds of optimistic chatters. Nothing gets the heart racing for us seasoned stock folks like an upcoming...

Continue Reading
Unveiling Federal Credit Lab: A Platform Revolution

Updated Category News Views 22

Navigating the Maze of Federal Lending Well, folks, in the tangled web of federal economics, there's a new player aiming to bring some much-needed clarity. Lafayette Square Institute and the Center for USA Lending have rolled out the Federal Credit Lab. Think of it as a treasure trove of data and insights on federal credit, set to become a trusty compass for policymakers,...

Continue Reading
Slim Chickens Redefines TV Dinners with Smart TV Orders

Updated Category News Views 147

Slim Chickens Takes Over Your Living Room Folks, it looks like the couch just became a whole lot more than a place to binge-watch shows. Slim Chickens is shaking things up by letting you order your favorite wings and tenders right from the Samsung Smart TV home screen in Northwest Arkansas. This hell of a move takes fast-casual dining to a whole new level, mixing the...

Continue Reading

Top 5 Most Recently Viewed Articles

Staying Informed: NET Power, Inc. Class Action Update

Updated Category News Views 116

Understanding the NET Power, Inc. Class Action In the realm of investment, class action lawsuits can have significant implications for shareholders, particularly in companies like NET Power, Inc. This lawsuit, initiated by Levi & Korsinsky, LLP, highlights critical information every investor should be aware of concerning their stakes in NET Power. Class Action Lawsuit...

Continue Reading
Pandora's Resilient Growth Amid Economic Challenges

Updated Category News Views 196

Financial Performance Overview Pandora continues to show resilience, achieving an impressive 8% organic growth in their recent quarter. Despite facing economic turbulence, including pressures from foreign exchange rates, tariffs, and changing commodity prices, the brand managed to sustain strong revenue and profit margins. Organic Growth Insights In the recent quarterly...

Continue Reading
Heineken N.V. Shares Buyback Program: Latest Updates

Updated Category News Views 294

Heineken N.V. Shares Buyback Program Overview Heineken N.V. is making notable strides in its current share buyback program, intensifying efforts to strengthen shareholder value while showcasing the company's commitment to sustained growth. The beverage giant has embarked on a significant initiative, pledging €1.5 billion to enhance its market position and boost investor...

Continue Reading
TCL SunPower Global: Leading the Charge for Solar Innovation

Updated Category News Views 309

TCL SunPower Global: A New Era in Solar Energy TCL SunPower Global has emerged as a groundbreaking entity within the TCL Group, dedicated to providing innovative solar energy solutions and redefining sustainable living. With a robust foundation built on 40 years of expertise, this venture is poised to lead the solar energy revolution, addressing the growing demand for...

Continue Reading
Coleridge Initiative Secures USDA Funding for Data Services

Updated Category News Views 74

Coleridge Initiative Receives Significant Funding from USDA The Coleridge Initiative has recently been awarded a contract worth up to $7.5 million by the U.S. Department of Agriculture (USDA). This funding is aimed at establishing a secure data enclave service that will greatly facilitate research and collaborative efforts across various sectors. The Importance of Secure...

Continue Reading